Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease.
Snydman
David R
DR
D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D016867:Immunocompromised Host; D011183:Postoperative Complications; D014180:Transplantation; D000077562:Valganciclovir
D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir